The European Patent Office (EPO) has published patent application EP4493274A1, detailing depot systems that include cariprazine or its salts. The application was filed by Mapi Pharma Ltd. and lists Shai Rubnov, Ehud Marom, and Anna Gopin as inventors. The publication date for this patent application is March 18, 2026.

This publication represents the grant of a patent for a specific pharmaceutical formulation. While it does not impose new regulatory obligations on drug manufacturers or pharmaceutical companies, it is a significant development in intellectual property for cariprazine-based therapies. Companies operating in this space should be aware of this patent for strategic planning and potential licensing considerations.